FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/04/108022 [Registered on: 09/04/2026] Trial Registered Prospectively
Last Modified On: 09/04/2026
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Process of Care Changes 
Study Design  Other 
Public Title of Study   A study to evaluate how rural hospitals are implementing Pediatric resuscitation and emergency medicine initiative a strategy to reduce child mortality 
Scientific Title of Study   Pediatric Resuscitation and Emergency Medicine (PREM): An Innovative Strategy to Empower Frontline Health Care Providers to Resuscitate Critically Ill or Injured Children in District Hospitals of Tamil Nadu – An Implementation Operational Study 
Trial Acronym  PREM 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Indumathy Santhanam 
Designation  Project Coordinator 
Affiliation  Regional Collaborative Center-Institute of Child Health and Hospital for Children, Egmore 
Address  Regional Collaborative Center- Institute of Child Health, A-Block, 2nd Floor, PREM Simulation Laboratory, Tamil Salai-Egmore, Chennai

Chennai
TAMIL NADU
600008
India 
Phone  9444466144  
Fax    
Email  indumathysanthanam@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Indumathy Santhanam 
Designation  Project Coordinator 
Affiliation  Regional Collaborative Center-Institute of Child Health and Hospital for Children, Egmore 
Address  Regional Collaborative Center- Institute of Child Health, A-Block, 2nd Floor, PREM Simulation Laboratory, Tamil Salai-Egmore, Chennai

Chennai
TAMIL NADU
600008
India 
Phone  9444466144  
Fax    
Email  indumathysanthanam@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Madhivannan 
Designation  Director, Institute of Child Health and Hospital for Children 
Affiliation  Institute of Child Health and Hospital for Children 
Address  Institute of Child Health and Hospital for Children, Tamil Salai, Egmore, Chennai

Chennai
TAMIL NADU
600008
India 
Phone  9840262428  
Fax  044-28191135  
Email  dr.madhi67@gmail.com  
 
Source of Monetary or Material Support  
Tamil Nadu Health System Project TNHSP, DMS Annex building DMS Campus 359 Anna Salai Teynampet Chennai 600006 
 
Primary Sponsor  
Name  Tamil Nadu Health System Project 
Address  Tamil Nadu Health System Project, 4th Floor-National Health Mission Building, DMS Annex,359,Anna Salai, Teynampet, Chennai, 600006 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 6  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr K Sasikala  Government Dharmapuri Medical College  Department of Pediatrics, Sick Neonatal Unit Building, Government Dharmapuri Medical College, Salem Main Road, Indira Nagar, 636701
Dharmapuri
TAMIL NADU 
9597410833

sasikumaran23@gmail.com 
Dr J Merceline Alice Pon Jeba  Government Kanyakumari Medical College  Department of Pediatrics,B Block, 1st Floor, Government Kanyakumari Medical College, Asaripallam, Nagercoil, 629201
Kanniyakumari
TAMIL NADU 
8903719802

mercelinejeba6141@gmail.com 
Dr E Vigneshwaran  Government Theni Medical College  Department of Pediatrics, RMO Office Building, Government Theni Medical College Dhanushkodi Road Theni 625512
Theni
TAMIL NADU 
9750866196

vigneshvas6@gmail.com 
Dr S Sathyapriya  Government Tiruppur Medical College  Department of Pediatrics, B Block, Government Tiruppur Medical College, Dharapuram Road, Velliangadu, 641604
Coimbatore
TAMIL NADU 
9976153997

dr.satpri@gmail.com 
Dr M Thanisulas  Government Virudhunagar Medical College  Department of Pediatrics, Maternal and Child Health Building, Government Virudhunagar Medical College, NH 44, Kooraikundu, 626002
Virudhunagar
TAMIL NADU 
8807900898

dr.thanis@gmail.com 
Indumathy Santhanam  Regional Collaborative Center  ICH A Block, 2nd Floor, PREM Simulation Laboratory, Tamil Salai Egmore 600008
Chennai
TAMIL NADU 
09444466144

indumathysanthanam@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 6  
Name of Committee  Approval Status 
Government Dharmapuri Medical College  Approved 
Government Kanyakumari Medical College  Approved 
Government Theni Medical College  Approved 
Government Tirupur Medical College  Approved 
Government Virudhunagar Medical College  Approved 
Institutional Ethics Committee Directorate of Public Health and Preventive Medicine, Chennai-600006  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: Z048||Encounter for examination and observation for other specified reasons,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Pediatric Resuscitation and Emergency Medicine (PREM) process   Strengthening infrastructure (1 week), training in PREM guidelines (1-day workshop), use of PREM case record to take clinical decisions, use appropriate drugs and consumables during resuscitation, and implement PREM triage protocol in the OPD to recognize and resuscitate sick children brought with apparently minor symptoms over 3 months.  
Comparator Agent  Standard care in practice in GH for triage and pediatric emergency care.   Comparator arm: Data will be collected on the standard care used by doctors and nurses prior to the intervention. GH acts as its own control or comparator pre and post intervention  
 
Inclusion Criteria  
Age From  1.00 Month(s)
Age To  12.00 Year(s)
Gender  Both 
Details  Children more than 30 days, less than 144 months 
 
ExclusionCriteria 
Details  Newborn, age more than 12 years, do not resuscitate status 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Acceptability: Acceptability of implementation measure,
Adoptability:
Number Initiated/number eligible for Initiation
Fidelity: Checklist or Likert Scale to evaluate how many components are implemented as instructed.
Penetration:
i)Proportion of doctors who routinely practice PREM protocols/ Total number of clinicians
ii)Number of patients who receive PREM protocol-based care/ Total number of patients
 
25 weeks to 36 weeks from base-line or start of study 
 
Secondary Outcome  
Outcome  TimePoints 
Number of critically ill children triaged every month, monthly bed occupancy rate in the children’s ward, No of children referred to higher centers after resuscitation, No of children referred without resuscitation, No of children with emergency signs who received critical interventions, Oxygen, fluid bolus, inotrope infusion, CPR, anticonvulsants, nebulization, antibiotics, No of children who were treated until the resolution of therapeutic goals, No of children with emergency signs who did not receive critical interventions, Oxygen, fluid bolus, inotrope infusion, CPR, anticonvulsants, nebulization, antibiotics, No of children who were inadequately treated, No of children who were refractory to treatment, quality of documentation in PREM case record during the study period.
 
Post implementation phase October, November, December 2026
25th week to 36 weeks 
Clinical care indicators:
No. of children treated with respiratory distress, pneumonia, asthma, or bronchiolitis, no. of children treated for hypovolemic shock with dehydration, number of children treated for septic /dengue shock, No of children treated for unresponsiveness with abnormal movements, No of children treated for envenomation, trauma, poisoning, or other pediatric emergencies.
 
April 2026 to March 2027 
Service quality indicators: Patient satisfaction score, number of children who left against medical advice
 
April 2026 to March 2027 
Mortality within 24 hours, mortality within 7 days for all children who are participating in the study.  April 2026 to March 2027 
 
Target Sample Size   Total Sample Size="5000"
Sample Size from India="5000" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/04/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [indumathysanthanam@gmail.com].

  6. For how long will this data be available start date provided 31-12-2027 and end date provided 31-12-2030?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

Background and Rationale

Around 2.6 million between the ages of 1 and 59 months, and 2.1 million children beyond 5 years have succumbed. Approximately 27% of these child deaths were reported from South Asia3,4. Diarrhoea, pneumonia, and sepsis remain important causes of post-neonatal under-5 mortality (U5M)5

This study has been undertaken to highlight the efforts taken by the National Health Mission Tamil Nadu in reducing U5M. Earlier, in 2017, the state’s post-neonatal U5M was high at 17/10006. Gap analysis revealed that critically ill children were being transferred to the medical college Pediatric ICUs without stabilization. Lack of infrastructure, drugs, consumables, equipment, and trained manpower were some of the reasons cited for the “scoop and run” policy.  

As a result, funds were sanctioned to provide training in Pediatric Resuscitation and Emergency Medicine (PREM means love in all Indian languages) protocols7 to front-line staff in district hospitals. PREM earlier known as PEMC was developed from lessons learned from a low-resource, large-volume pediatric emergency department which was staffed by novice residents with little exposure to emergency medicine training in their undergraduate period. A cyclical process was innovated to enable junior front-line doctors to assess the physiological status using the PREM triangle to make therapeutic decisions until stabilization. This approach reduced the need for senior advice, invasive monitoring, and mechanical ventilation and improved in-hospital mortality over 2 decades. 

Based on this data, PREM units were set up in 28 District headquarters/Taluk hospitals, and 4 nurses were recruited per unit8. In 2019, the TN H&FW passed a comprehensive Government Order that adopted PREM protocols and training content9. Additionally, the state Planning Commission, under the Tamil Nadu Innovative Initiative Fund, sanctioned a high-fidelity simulation laboratory to train doctors and nurses in PREM protocols at the Institute of Child Health-Madras Medical College. 

Post covid, in 2022, NHM-TN extended the PREM initiative to 94 hospitals: Medical colleges, DHQ, and Taluk. Monthly, state-level PREM death audits were conducted via Zoom with all the stakeholders. Daily PREM performance was submitted to the NHM via the Google platform. 

Since the implementation of PREM, annually around 50,000 acutely ill children are being evaluated and resuscitated and the U5M in 2023, TN has dropped to 8.2/1000. However, little evidence exists in support of the PREM initiative.  

 

Research question

How does the implementation of PREM influence the resuscitation care provided to critically ill or injured children in secondary care, low resource rural hospitals and what system-level, and behavioral factors shape adherence to PREM protocol-based care?

 Primary objectives

1)    To assess the reach, effectiveness, acceptability, adoption, appropriateness, feasibility, fidelity, and penetration following PREM implementation, in 5 rural district hospitals.

Secondary objective:  

The pre and post analysis will be made with respect to the base-line levels of the facility

i)   To assess the proportion of children who were triaged as critically-ill using PREM triage process in the out-patient department.

ii)  To measure compliance with PREM protocols for airway obstruction/ respiratory distress, shock and non-convulsive status epilepticus following successful triage in OPD.   

iii)           To determine compliance with PREM protocols for children rushed into the PREM unit with overt paediatric emergencies.

iv)            To determine the proportion of compliance with PREM documentation and decision-making guidelines during resuscitation.

v)             Proportion transferred out with or without PREM based resuscitation

Methods:

IEC committee of the Directorate of Public health and Preventive Medicine has given approval for conducting the study at the 5 secondary care hospitals (Usilampatti DHQ hospital, Rajapalayam GH, Palladam GH, Pennagaram GH and Kuzhithurai GH. IEC approval is under process in 5 medical college hospitals (Theni Medical College, Virudhunagar Medical College, Tiruppur Medical College, Dharmapuri Medical College and Kanyakumari Medical College) for mentoring and guiding the study sites.  

This is a prospective multicenter before and after implementation-operational study using the RE-AIM framework that will be conducted in 5 secondary care hospitals in rural Tamil Nadu. Quantitative and qualitative data will be obtained prior to the implementation phase:  

Phase I – Pre-implementation (3 months):

Qualitative data

Focused group discussion will be held with the stakeholders in the district hospital to understand, the reach, effectiveness, acceptability, adoptability, feasibility and maintenance of the implementation study. Interviews with key clinical/management leaders will be conducted to determine the nature and extent of site barriers to the implementation pathway and training of the staff.

Quantitative data

i) Baseline audit of medical records/ hospital registers to determine baseline clinical performance and PREM pathway performance.  

  1. To compare, the proportion of children who present to OPD/ PREM unit with a documented assessment for severity of physiological status before and after the intervention.
  2. To compare, the number of children who present to OPD/PREM unit who received PREM based resuscitation before and after the intervention.
  3. To compare, whether the care provided to children who present to a hospital is consistent with PREM protocols before and after the intervention.
  4. To compare, whether there is a change over time during the study period in the above-mentioned outcomes.

 iii) Audit of PREM infrastructure 

Phase II – Implementation strategy (3 months):

Based on the qualitative and quantitative evaluation, infrastructure and essential resources will be strengthened, PREM training will be provided, and continuous monitoring will be enhanced by the mentoring medical college hospitals. 

Phase III – Post-implementation Evaluation (3 months):Ongoing data collection from participating sites will evaluate the following:  

i) Surveys will be conducted to evaluate acceptability, adoptability, feasibility, penetration and fidelity during this phase.

ii) Number of clinicians and nurses who underwent training.  

iii) Number who used the PREM triage process in the OPD

iv) Number who used the PREM team approach for unresponsiveness

v)Number who are using PREM case records to document

vi) Comparative analysis with baseline data will assess improvements in timely recognition, appropriate resuscitation interventions, and clinical outcomes among critically ill children.

Inclusion criteria

Qualitative and quantitative survey will be collected from the following district hospital participants after obtaining informed consent:

1)    Chief medical officer

2)    Doctors who are posted in the emergency department i.e. Paediatricians and non-paediatricians

3)    Nurses who rotate in the emergency department and paediatrics/ PREM unit

4)    Matron and nursing supervisors

Exclusion criteria

1)    Doctors who are not posted in the Emergency Department

2)    Nurses who work exclusively in the sick neonatal unit/labor ward/OR etc

Outcome Indicators:

Acceptability: Acceptability of implementation measure

Adoptability: Number Initiated/number eligible for Initiation

Fidelity: Checklist or Likert Scale to evaluate how many components are implemented as instructed.

Penetration:

i)               Proportion of doctors who routinely practice PREM protocols/ Total number of clinicians

ii)             Number of patients who receive PREM protocol-based care/ Total number of patients Audits and checklist (See below)

Efficiency indicators:

  1. Number of critically ill children triaged every month.
  1. The monthly bed occupancy rate in the children’s ward.
  2. No of children referred to higher centres after resuscitation.
  3. No of children referred without resuscitation.
  4. No of children with emergency signs who received critical interventions, Oxygen, fluid bolus, inotrope infusion, CPR, anticonvulsants, nebulization, antibiotics.
  5. No of children who were treated until the resolution of therapeutic goals.
  6. No of children with emergency signs who did not receive critical interventions, Oxygen, fluid bolus, inotrope infusion, CPR, anticonvulsants, nebulization, antibiotics.
  7. No of children who were inadequately treated
  8. No of children who were refractory to treatment.
  9. Quality of documentation in PREM case record during the study period.

Clinical care indicators:

  1. No. of children treated with respiratory distress, pneumonia, asthma, or bronchiolitis.
  2. No. of children treated for hypovolemic shock with dehydration.
  3. Number of children treated for septic /dengue shock
  4. No of children treated for unresponsiveness with abnormal movements
  5. No of children treated for envenomation, trauma, poisoning, or other pediatric emergencies.
  6. Mortality within 24 hours, mortality within 7 days for all children who are participating in the study.

Service quality indicators:

  1. Patient satisfaction score
  2. The number of children who LAMA


 
Close